A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
מצבים רפואיים
Nasopharyngeal Cancer Recurrent
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Contact: Principal Investigator (Santanu Samanta, MD)University of California, Irvine, Irvine, California, United States
Contact: Principal Investigator (Bao-An Huynh)University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Sue S Yom, MD)Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Dong Shin, MD)Boston Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Peter C Everett, MD)University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Paul Swiecicki, MD)Henry Ford Cancer Center, Detroit, Michigan, United States
Contact: Principal Investigator (Matthew Wilkins, MD)Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Trisha M Wise-Draper, M.D., Ph.D.)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Tamara Sussman, MD)Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Contact: Principal Investigator (Danh Pham, MD)Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Stuart Wong, MD)Princess Margaret Cancer Centre, Toronto, Canada
Contact: Principal Investigator (Anna Spreafico, MD, PhD)
מובילי המחקר
Study Director
Coherus Oncology